This track focuses on the latest developments in MRI and computed tomography imaging technologies for cancer diagnosis. It aims to explore their applications in enhancing the accuracy and efficacy of cancer detection.

This session will delve into the advancements in positron emission tomography (PET) imaging, particularly in its integration with CT and MRI. Participants will discuss the implications of hybrid imaging techniques on cancer diagnosis and treatment planning.

This track will investigate the role of biomarkers in the early detection and management of breast and lung cancers. Emphasis will be placed on the identification of novel biomarkers and their potential for personalized treatment strategies.

This session will explore the significance of biomarkers in the diagnosis and treatment of prostate and blood cancers. Discussions will include the latest research findings and their implications for clinical practice.

This track will focus on the discovery and validation of biomarkers specific to colorectal and ovarian cancers. The session aims to highlight their potential in improving patient outcomes through targeted therapies.

This session will examine the rationale behind targeted therapies and immunotherapy in cancer treatment. Participants will discuss the latest evidence supporting their use and the challenges faced in clinical implementation.